开云app官网登录入口网页版-官方正版

#伴随诊断#

15篇内容 | 837人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2222850, encodeId=00032222850bf, content=<a href='/topic/show?id=326f2610414' target=_blank style='color:#2F92EE;'>#伴随诊断#</a> <a href='/topic/show?id=cbbf11845301' target=_blank style='color:#2F92EE;'>#癌症生物标志物检测#</a>, objectTitle=单次检测可覆盖500多个基因！美国食品药品监督管理局（FDA）批准因美纳癌症生物标志物检测试剂盒及其两项伴随诊断适应症, objectType=article, longId=840366, objectId=c63f840366e1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20231103/1698995635796_8096338.jpg, objectUrl=/article/show_article.do?id=c63f840366e1, replyNumber=0, likeNumber=16, createdTime=2024-08-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c63f840366e1, moduleTitle=单次检测可覆盖500多个基因！美国食品药品监督管理局（FDA）批准因美纳癌症生物标志物检测试剂盒及其两项伴随诊断适应症, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c63f840366e1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1956437, encodeId=adad195643ebb, content=<a href='/topic/show?id=326f2610414' target=_blank style='color:#2F92EE;'>#伴随诊断#</a>, objectTitle=中国上市的适应症！罗氏VENTANA PD-L1（SP263）检测作为治疗尿路上皮癌的伴随诊断获批上市, objectType=article, longId=194187, objectId=a31b19418e54, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a31b19418e54, replyNumber=0, likeNumber=55, createdTime=2020-12-09, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a31b19418e54, moduleTitle=中国上市的适应症！罗氏VENTANA PD-L1（SP263）检测作为治疗尿路上皮癌的伴随诊断获批上市, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=a31b19418e54)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956438, encodeId=a15d1956438a8, content=<a href='/topic/show?id=326f2610414' target=_blank style='color:#2F92EE;'>#伴随诊断#</a>, objectTitle=FDA批准FoundationOne CDx作为Vitrakvi（larotrectinib）的伴随诊断剂，以帮助鉴定NTRK融合阳性患者, objectType=article, longId=202449, objectId=39aa20244938, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39aa20244938, replyNumber=0, likeNumber=59, createdTime=2021-03-10, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39aa20244938, moduleTitle=FDA批准FoundationOne CDx作为Vitrakvi（larotrectinib）的伴随诊断剂，以帮助鉴定NTRK融合阳性患者, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=39aa20244938)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956436, encodeId=a6951956436f2, content=<a href='/topic/show?id=326f2610414' target=_blank style='color:#2F92EE;'>#伴随诊断#</a>, objectTitle=精准医疗的突破：FoundationOne CDx癌症基因组谱可用于Rozlytrek治疗ROS1阳性肺癌的伴随诊断, objectType=article, longId=185334, objectId=f8d0185334ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8d0185334ad, replyNumber=0, likeNumber=64, createdTime=2020-07-04, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8d0185334ad, moduleTitle=精准医疗的突破：FoundationOne CDx癌症基因组谱可用于Rozlytrek治疗ROS1阳性肺癌的伴随诊断, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f8d0185334ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956435, encodeId=a527195643573, content=<a href='/topic/show?id=326f2610414' target=_blank style='color:#2F92EE;'>#伴随诊断#</a>, objectTitle=Hematogenix针对三阴乳腺癌推出获得FDA批准的伴随诊断肿瘤免疫检测, objectType=article, longId=162296, objectId=bc66162296de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc66162296de, replyNumber=0, likeNumber=77, createdTime=2019-09-13, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc66162296de, moduleTitle=Hematogenix针对三阴乳腺癌推出获得FDA批准的伴随诊断肿瘤免疫检测, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=bc66162296de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956434, encodeId=ab60195643404, content=<a href='/topic/show?id=326f2610414' target=_blank style='color:#2F92EE;'>#伴随诊断#</a>, objectTitle=CLIN CHEM：黑色素瘤患者血浆中循环肿瘤DNA的液体分析用于伴随诊断和BRAF抑制剂治疗的监测, objectType=article, longId=138830, objectId=1e7b1388303f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e7b1388303f, replyNumber=0, likeNumber=63, createdTime=2018-10-01, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e7b1388303f, moduleTitle=CLIN CHEM：黑色素瘤患者血浆中循环肿瘤DNA的液体分析用于伴随诊断和BRAF抑制剂治疗的监测, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=1e7b1388303f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956432, encodeId=2d8b1956432b3, content=<a href='/topic/show?id=326f2610414' target=_blank style='color:#2F92EE;'>#伴随诊断#</a>, objectTitle=【WCLC 2017】FLAURA研究伴随诊断结果公布：血浆EGFR突变阳性与组织阳性患者接受奥希替尼一线治疗获益一致, objectType=article, longId=116656, objectId=7181116656ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7181116656ed, replyNumber=0, likeNumber=62, createdTime=2018-05-29, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7181116656ed, moduleTitle=【WCLC 2017】FLAURA研究伴随诊断结果公布：血浆EGFR突变阳性与组织阳性患者接受奥希替尼一线治疗获益一致, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=7181116656ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956433, encodeId=bf4219564335c, content=<a href='/topic/show?id=326f2610414' target=_blank style='color:#2F92EE;'>#伴随诊断#</a>, objectTitle=祝贺！又一款NGS伴随诊断获批（可检测324个基因、靶向5种癌症……）, objectType=article, longId=122153, objectId=e769122153e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e769122153e4, replyNumber=0, likeNumber=67, createdTime=2018-09-26, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e769122153e4, moduleTitle=祝贺！又一款NGS伴随诊断获批（可检测324个基因、靶向5种癌症……）, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e769122153e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956430, encodeId=f8731956430bb, content=<a href='/topic/show?id=326f2610414' target=_blank style='color:#2F92EE;'>#伴随诊断#</a>, objectTitle=厉害了，肿瘤液体活检！cfDNA伴随诊断成功案例分析, objectType=article, longId=89452, objectId=217c89452fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=217c89452fb, replyNumber=0, likeNumber=70, createdTime=2018-01-26, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=217c89452fb, moduleTitle=厉害了，肿瘤液体活检！cfDNA伴随诊断成功案例分析, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=217c89452fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956431, encodeId=1fd419564310f, content=<a href='/topic/show?id=326f2610414' target=_blank style='color:#2F92EE;'>#伴随诊断#</a>, objectTitle=个性化医疗时代的双生花：伴随诊断和靶向治疗药物, objectType=article, longId=91996, objectId=7bf59199684, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bf59199684, replyNumber=0, likeNumber=68, createdTime=2018-01-30, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bf59199684, moduleTitle=个性化医疗时代的双生花：伴随诊断和靶向治疗药物, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=7bf59199684)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956428, encodeId=09431956428c3, content=<a href='/topic/show?id=326f2610414' target=_blank style='color:#2F92EE;'>#伴随诊断#</a>, objectTitle=伴随诊断助力癌症精准治疗, objectType=article, longId=80255, objectId=8be380255e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8be380255e1, replyNumber=0, likeNumber=63, createdTime=2017-04-19, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8be380255e1, moduleTitle=伴随诊断助力癌症精准治疗, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=8be380255e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956429, encodeId=6c2619564292e, content=<a href='/topic/show?id=326f2610414' target=_blank style='color:#2F92EE;'>#伴随诊断#</a>, objectTitle=伴随诊断助力癌症精准治疗, objectType=article, longId=80706, objectId=aa6b80e06a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa6b80e06a1, replyNumber=0, likeNumber=80, createdTime=2017-07-02, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa6b80e06a1, moduleTitle=伴随诊断助力癌症精准治疗, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=aa6b80e06a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956427, encodeId=2b05195642efd, content=<a href='/topic/show?id=326f2610414' target=_blank style='color:#2F92EE;'>#伴随诊断#</a>, objectTitle=抗癌药物的伴随诊断，下一代测序(NGS)扮演何种角色？, objectType=article, longId=59084, objectId=d09e5908449, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d09e5908449, replyNumber=0, likeNumber=64, createdTime=2016-10-05, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d09e5908449, moduleTitle=抗癌药物的伴随诊断，下一代测序(NGS)扮演何种角色？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=d09e5908449)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956426, encodeId=1a4319564269e, content=<a href='/topic/show?id=326f2610414' target=_blank style='color:#2F92EE;'>#伴随诊断#</a>, objectTitle=盟批准阿斯利康易瑞沙（Iressa）血液ctDNA伴随诊断, objectType=article, longId=40988, objectId=5fe04098847, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fe04098847, replyNumber=0, likeNumber=66, createdTime=2015-05-24, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fe04098847, moduleTitle=盟批准阿斯利康易瑞沙（Iressa）血液ctDNA伴随诊断, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=5fe04098847)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956425, encodeId=b3db1956425d1, content=<a href='/topic/show?id=326f2610414' target=_blank style='color:#2F92EE;'>#伴随诊断#</a>, objectTitle=欧盟批准阿斯利康易瑞沙（Iressa）血液ctDNA伴随诊断, objectType=article, longId=40977, objectId=524c409e78d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=524c409e78d, replyNumber=0, likeNumber=74, createdTime=2014-12-03, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=524c409e78d, moduleTitle=欧盟批准阿斯利康易瑞沙（Iressa）血液ctDNA伴随诊断, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=524c409e78d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956424, encodeId=af2f195642466, content=<a href='/topic/show?id=326f2610414' target=_blank style='color:#2F92EE;'>#伴随诊断#</a>, objectTitle=**肺癌全自动免疫组化伴随诊断试剂盒在华获批上市, objectType=article, longId=26579, objectId=9ab3265e951, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ab3265e951, replyNumber=0, likeNumber=65, createdTime=2014-06-11, rootId=0, userName=ms2186806800017884, userId=24c12500054, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ab3265e951, moduleTitle=**肺癌全自动免疫组化伴随诊断试剂盒在华获批上市, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=9ab3265e951)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

伴随诊断

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#伴随诊断# #癌症生物标志物检测#

单次检测可覆盖500多个基因！美国食品药品监督管理局（FDA）批准因美纳癌症生物标志物检测试剂盒及其两项伴随诊断适应症

2024-08-28发表于上海

ms2186806800017884 (审核中...)

前往app查看评论内容

#伴随诊断#

中国上市的适应症！罗氏VENTANA PD-L1（SP263）检测作为治疗尿路上皮癌的伴随诊断获批上市

2020-12-09

ms2186806800017884 (审核中...)

前往app查看评论内容

#伴随诊断#

FDA批准FoundationOne CDx作为Vitrakvi（larotrectinib）的伴随诊断剂，以帮助鉴定NTRK融合阳性患者

2021-03-10

ms2186806800017884 (审核中...)

前往app查看评论内容

#伴随诊断#

精准医疗的突破：FoundationOne CDx癌症基因组谱可用于Rozlytrek治疗ROS1阳性肺癌的伴随诊断

2020-07-04

ms2186806800017884 (审核中...)

前往app查看评论内容

#伴随诊断#

Hematogenix针对三阴乳腺癌推出获得FDA批准的伴随诊断肿瘤免疫检测

2019-09-13

ms2186806800017884 (审核中...)

前往app查看评论内容

#伴随诊断#

CLIN CHEM：黑色素瘤患者血浆中循环肿瘤DNA的液体分析用于伴随诊断和BRAF抑制剂治疗的监测

2018-10-01

ms2186806800017884 (审核中...)

前往app查看评论内容

#伴随诊断#

【WCLC 2017】FLAURA研究伴随诊断结果公布：血浆EGFR突变阳性与组织阳性患者接受奥希替尼一线治疗获益一致

2018-05-29

ms2186806800017884 (审核中...)

前往app查看评论内容

#伴随诊断#

祝贺！又一款NGS伴随诊断获批（可检测324个基因、靶向5种癌症……）

2018-09-26

ms2186806800017884 (审核中...)

前往app查看评论内容

#伴随诊断#

厉害了，肿瘤液体活检！cfDNA伴随诊断成功案例分析

2018-01-26

ms2186806800017884 (审核中...)

前往app查看评论内容

#伴随诊断#

个性化医疗时代的双生花：伴随诊断和靶向治疗药物

2018-01-30

ms2186806800017884 (审核中...)

前往app查看评论内容

#伴随诊断#

伴随诊断助力癌症精准治疗

2017-04-19

ms2186806800017884 (审核中...)

前往app查看评论内容

#伴随诊断#

伴随诊断助力癌症精准治疗

2017-07-02

ms2186806800017884 (审核中...)

前往app查看评论内容

#伴随诊断#

抗癌药物的伴随诊断，下一代测序(NGS)扮演何种角色？

2016-10-05

ms2186806800017884 (审核中...)

前往app查看评论内容

#伴随诊断#

盟批准阿斯利康易瑞沙（Iressa）血液ctDNA伴随诊断

2015-05-24

ms2186806800017884 (审核中...)

前往app查看评论内容

#伴随诊断#

欧盟批准阿斯利康易瑞沙（Iressa）血液ctDNA伴随诊断

2014-12-03

ms2186806800017884 (审核中...)

前往app查看评论内容

#伴随诊断#

**肺癌全自动免疫组化伴随诊断试剂盒在华获批上市

2014-06-11

科室
- - 订阅+
  - 更多科室
工具
服务